| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.09T | 1.13T | 1.16T | 1.13T | 911.43B | 863.38B |
| Gross Profit | 463.24B | 479.42B | 504.68B | 485.94B | 392.74B | 374.65B |
| EBITDA | 44.77B | -60.74B | 106.18B | -16.80B | 60.35B | 66.32B |
| Net Income | -37.11B | -47.85B | 4.52B | -103.15B | -26.12B | -15.21B |
Balance Sheet | ||||||
| Total Assets | 1.17T | 1.22T | 1.39T | 1.41T | 1.34T | 1.30T |
| Cash, Cash Equivalents and Short-Term Investments | 86.36B | 89.90B | 127.13B | 183.06B | 117.67B | 123.82B |
| Total Debt | 432.36B | 438.17B | 522.58B | 568.29B | 448.65B | 410.70B |
| Total Liabilities | 687.86B | 743.56B | 834.67B | 913.90B | 776.62B | 749.05B |
| Stockholders Equity | 466.93B | 463.15B | 539.82B | 487.42B | 549.81B | 539.89B |
Cash Flow | ||||||
| Free Cash Flow | 2.99B | 25.30B | 38.21B | -27.46B | -23.61B | 37.86B |
| Operating Cash Flow | 47.55B | 51.09B | 83.34B | 13.32B | 37.44B | 78.06B |
| Investing Cash Flow | 17.57B | 24.65B | -44.53B | -37.50B | -51.00B | -34.33B |
| Financing Cash Flow | -83.65B | -110.90B | -96.85B | 84.32B | 2.13B | -13.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $680.75B | 13.62 | 7.77% | 3.83% | 4.30% | 78.29% | |
78 Outperform | $4.28T | 16.89 | 7.92% | 1.83% | 5.39% | 12.69% | |
76 Outperform | €697.85B | 17.52 | 10.63% | 2.08% | 5.40% | 23.70% | |
66 Neutral | ¥787.32B | 13.00 | 5.91% | 2.94% | 4.46% | 70.22% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
50 Neutral | $266.56B | -7.27 | -12.69% | 0.78% | -11.22% | -731.07% |
Konica Minolta, Inc. is a multinational technology company based in Japan, primarily engaged in the development, manufacturing, and sales of imaging products and services, including office equipment, industrial optical systems, and healthcare solutions. The company is listed on the Tokyo Stock Exchange’s Prime Market.
Konica Minolta reported its consolidated financial results for the six months ending September 30, 2025, showing a revenue of 513,160 million yen, an 8% decrease from the previous year. Despite the revenue drop, the company saw a significant improvement in business contribution profit, operating profit, and profit attributable to owners, reflecting a positive turnaround in its financial performance. The company’s equity ratio also improved to 41.6%, indicating a stronger financial position. The announcement highlights the discontinuation of the Precision Medicine Business, focusing on continuing operations, and a dividend of 5 yen per share for the fiscal year ending March 31, 2026, signaling a commitment to shareholder returns.
The most recent analyst rating on (JP:4902) stock is a Hold with a Yen529.00 price target. To see the full list of analyst forecasts on Konica Minolta stock, see the JP:4902 Stock Forecast page.